Veriheal

FEBRUARY 21, 2023

As medicinal and recreational cannabis legalization continues to sweep across the United States, a recent study paints a concerning portrait of many states denying or restricting medical marijuana (MMJ) access. How Do MMJ Restrictions Affect Patients and Doctors? Many patients take MMJ for more reasons than one.

Access 98

Access Patients Chronic Pain Conditions 98

Cannabis Law Report

SEPTEMBER 29, 2022

Australia’s drugs regulator issues 73 infringement notices over claims prescriptions could treat conditions such as cancer and epilepsy. The Therapeutic Goods Administration (TGA) issued 73 infringement notices totalling $972,360 between the medicinal cannabis companies MGC Pharmaceuticals Ltd, Cannatrek Ltd and Little Green Pharma Ltd.

Epilepsy 52

Epilepsy Conditions Media Medicine 52

Cannabis Info

MARCH 2, 2019

Marijuana as a treatment for epilepsy. Medical cannabis is showing great potential in the treatment of epilepsy. Cannabis has been shown in several studies to successfully treat seizures , completely eradicating them in some cases. WHAT EXACTLY IS EPILEPSY? CONVENTIONAL TREATMENT.

Epilepsy 69

Epilepsy Treatment Marijuana Research and Development 69

MMJ Recs

NOVEMBER 20, 2023

This article delves into the science behind medical marijuana, focusing on cannabinoids, the active compounds found in the cannabis plant, and their remarkable therapeutic effects. THC is the primary psychoactive compound in cannabis, responsible for the “high” or euphoric feeling associated with marijuana use.

Cannabinoids 98

Cannabinoids Epilepsy Treatment Marijuana 98

Cannabis Law Report

JUNE 5, 2019

Press Release: Thailand Government Pharmaceutical Organization. The Pharmaceutical Organization, Department of Medical Affairs, signed a joint research on standard quality medical marijuana extracts for patients with chemo-allergic cancer, epilepsy, muscle contraction in patients with deteriorating nerve sheaths.

Pharmaceutical 40

Pharmaceutical Extraction Epilepsy Research and Development 40

Cannabis Law Report

JULY 30, 2019

Following an encouraging initial US launch, GW Pharmaceuticals’s cannabidiol oral solution is also set to achieve European approval later in 2019. Knowledge, attitudes and policies regarding medical cannabis and cannabis-based drugs are changing. Here are the takeaways ( Source Fitch). Source: [link].

Epilepsy 40

Epilepsy Pharmaceutical Medicine Treatment 40

MMJ Recs

MAY 15, 2022

This initial MMJ legislation only allowed patients suffering from intractable epilepsy to use cannabis oil. In 2020, the law changed to allow patients with any medical condition to receive a doctor’s recommendation to use and purchase medical marijuana products containing a maximum 10 milligrams of THC.

Patients 52

Patients Marijuana Pharmaceutical Dispensary 52

Cannabis Law Report

SEPTEMBER 24, 2019

Here is the BBC report and below you will find the full press release from GW Pharmaceuticals. T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. Medical cannabis costs family £4,000 a month to help teenager.

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

Cannabis Law Report

AUGUST 17, 2021

reduction in 28-day seizure frequency relative to baseline in tuberous sclerosis complex (TSC) patients (n=23). reduction was observed in focal seizures (n=19), the most common seizure type in TSC patients. Phase 3 planning for TrustTSC trial ongoing with first patient expected to be enrolled in Q4 2021. RADNOR, Pa.–(BUSINESS

Pharmaceutical 98

Pharmaceutical Clinical Trials Treatment Patients 98

MMJ Recs

APRIL 1, 2024

CBD, one of the many cannabinoids found in the cannabis plant, has been garnering attention for its promising effects on various health conditions. Studies have suggested that CBD may help manage chronic pain, reduce anxiety and depression, alleviate symptoms of epilepsy, and even aid in cancer treatment.

CBD 52

CBD Clinical Trials Chronic Pain Epilepsy 52

MMJ Recs

NOVEMBER 17, 2023

This article explores the profound impact of MMJ on Maryland communities, shedding light on the medical marijuana benefits experienced by patients and the positive effects it has had on the state’s communities. It has improved the quality of life for those dealing with chronic pain, nausea, seizures, and other medical conditions.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

CannaTech

JANUARY 16, 2019

Thanks to the recent emergence of regulated medical cannabis markets, the success of this versatile plant can be followed from farm to pharma and prescriber to patient, however, the origins of cannabis as medicine cannot be as simply traced as the plant is today from seed to sale. It is not a story about profiting off of people.

Access 89

Access Patients Pharmaceutical Education 89

Cannabis Law Report

AUGUST 24, 2021

BALTIMORE–(BUSINESS WIRE)– $MYMD — MyMD Pharmaceuticals, Inc. Thus, there is a great need to develop new and effective therapeutics for treating patients. About MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc.

Pharmaceutical 98

Pharmaceutical Clinical Trials Chronic Pain CBD 98

MGC Pharma

NOVEMBER 1, 2017

This is a big moment for me and the MGC Pharmaceuticals team. Needless to say, I have been waiting a long time to write the following sentence: MGC Pharmaceuticals has just released their first product to the market. CannEpil™ is CBD-based medication that is used as a treatment for people with refractory epilepsy.

Epilepsy 100

Epilepsy Pharmaceutical Medicine CBD 100

Cannabis Law Report

JANUARY 15, 2019

British firm GW Pharmaceuticals is licking its wounds after US judges tossed out its attempt to patent multiple cannabinoids for epilepsy treatment following an eight-year battle. The patent, which has been embroiled in dispute since 2010, is for “the use of one or more cannabinoids in the treatment of epilepsy”.

Epilepsy 71

Epilepsy Cannabinoids Treatment Research and Development 71

SpeedWeed

MARCH 30, 2021

THE UK’s first National Health Service patients registry will start collating data from Thursday this week in a significant move for medical cannabis in the country. The development has been welcomed and comes as the nation’s doctors are said to be shifting their cultural stance from viewing ‘cannabis as a dirty word’.

Data 52

Data Patients Clinical Trials Business 52

United Patients Group

APRIL 18, 2023

Introduction The medical cannabis industry is booming. However, there are still many myths about cannabis that persist despite being debunked by medical professionals and researchers alike. Myth: Cannabis is just a drug. Cannabis is a plant. Myth: Cannabis is a gateway to other drugs. Myth: Cannabis is a cure-all.

Research and Development 108

Research and Development Indica Treatment Conditions 108

MGC Pharma

APRIL 4, 2018

A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals. CBD-based treatment for people with Refractory Epilepsy?—?is Refractory Epilepsy is epilepsy that involves frequent and severe seizures that are difficult to treat. CannEpil™?—?CBD-based

Epilepsy 100

Epilepsy Pharmaceutical Research and Development CBD 100

Cannabis Law Report

DECEMBER 11, 2021

A Manchester MP’s bid to open up cannabis treatments on the NHS has been blocked by Tory backbenchers in the House of Commons. 'A Despite the Government legalising medicinal cannabis in 2018, following a number of high-profile campaigns, thousands of people are still being denied access to the treatment. Read more at.

Treatment 52

Treatment Access Patients Medicine 52

The Cannigma

JUNE 1, 2021

While France has long been said to have the highest number of cannabis users per capita in Europe, it has long lagged behind its western Europe neighbors when it comes to tolerance of the plant. Marijuana is not legal in France, and the country is seen as having some of the strictest cannabis policies in western Europe. Shutterstock.

Law 113

Law Epilepsy Programs Patients 113

Cannabis Law Report

AUGUST 4, 2022

Following the keenly anticipated June approval of its cannabis-derived Epidiolex, GW Pharmaceuticals $GWPH has finally launched the rare epilepsy drug in the United States. Epidiolex is sourced from natural cannabis grown by the British drugmaker in the United Kingdom.

Epilepsy 52

Epilepsy Therapy Patients Treatment 52

Cannabis Law Report

JULY 7, 2022

Eleven of thirteen cannabis patent claims survive PTAB challenge. filed a petition requesting inter partes review of claims 1-13 of GW Pharmaceutical Ltd.’s s patent directed to the use of cannabinoids, including cannabidiol (“CBD”), in the treatment of certain types of epilepsy. GW Pharma Limited and Otsuka Pharmaceutical Co.,

Epilepsy 52

Epilepsy Pharmaceutical Treatment Cannabinoids 52

Cannabis Law Report

JANUARY 16, 2022

The government will review the Dangerous Drugs Act 1952 and the Poisons Act 1952 to regulate cannabis and ketum for medical use, Health Minister Khairy Jamaluddin said. Cannabis, or marijuana, is currently banned under the Dangerous Drugs Act that imposes extremely harsh penalties for the use of illegal narcotics.

Research and Development 98

Research and Development Pharmaceutical Epilepsy Medicine 98

MGC Pharma

DECEMBER 12, 2017

A word from Elad Segev, Manager of Breeding and Cultivation at MGC Pharmaceuticals. A Cannabis plant is made up of 400 different chemicals that have physical and psychoactive effects when consumed together. Cannabinoids Many of the components found in Cannabis plants are known as cannabinoids. You can learn more about that here.

Epilepsy 100

Epilepsy Cannabinoids Pharmaceutical THC 100

United Patients Group

FEBRUARY 2, 2023

Using Cannabis For Health and Wellness Introduction Cannabis is a plant that has been used for thousands of years to treat many ailments. The first recorded use of cannabis was in 2737 BC, when Emperor Shen Nung documented its value as a medicine. But what exactly is cannabis? This is where cannabis comes in!

Blood Pressure 103

Blood Pressure Sleep Chronic Pain Digestion 103

Cannabis Law Report

APRIL 20, 2022

Growing demand in Poland for medical cannabis. WROCLAW, Poland , April 19, 2022 /PRNewswire/ — Can4Med , a licensed wholesale specializing in medical products containing THC and cannabinoids has obtained Polish authorization to supply medical products and raw materials for cannabis pharmaceutical sales.

Pharmaceutical 52

Pharmaceutical Patients Medicine Epilepsy 52

Cannabis Law Report

MAY 9, 2022

Celadon is one of the few firms that grow medical cannabis in the UK but, unlike others, uses an indoor lab rather than greenhouses. However, medical cannabis can only be prescribed by specialist doctors, patients often pay for it themselves, and it cannot be imported until a prescription has been issued, on a named-patient basis.

Chronic Pain 52

Chronic Pain Epilepsy Oil Pharmaceutical 52

LifeCannMD

NOVEMBER 24, 2023

You will need to receive a new patient evaluation from a Florida-certified Medical Marijuana doctor in order to determine your eligibility and give a medical marijuana recommendation. Cannabis doctors charge different consultation fees which are not covered by insurance at this time.

Marijuana 52

Marijuana Chronic Pain Conditions Strains 52

MMJ Recs

FEBRUARY 3, 2024

In recent years, the landscape of medical marijuana laws has evolved, presenting new opportunities and challenges for patients, healthcare providers, and industry stakeholders. These laws outline the parameters for the cultivation, distribution, and use of medical cannabis within the city.

Legislation 52

Legislation Law Marijuana Dispensary 52

Cannabis Law Report

JULY 24, 2019

Dr Mikael Sodergren , Managing Director and Academic Lead at Sapphire Medical Clinics said: “Medicinal cannabis is a new and exciting field. Our clinics are based on the premise that patients are treated by our world-renowned specialists in the relevant condition.

Epilepsy 40

Epilepsy Medicine Treatment Patients 40

SpeedWeed

AUGUST 9, 2021

Buenos Aires National Children’s Garrahan Hospital just provided the first supply of medical cannabis in Buenos Aires, the capital of Argentina. . Argentinian health authorities are now providing access to cannabis derivatives for medicinal, therapeutic and palliative purposes. The first shipment of the solution will treat 14 kids. .

Epilepsy 52

Epilepsy Research and Development Medicine Patients 52

Veriheal

SEPTEMBER 16, 2020

Though cannabis is becoming increasingly legal across the nation, both for recreational and medical purposes, there’s no sign that the US government intends to legalize cannabis on the federal level. This causes complications as more people than ever before are exploring cannabis for medical purposes. What is Epidiolex?

Access 97

Access Epilepsy Treatment Conditions 97

The Fresh Toast

MARCH 5, 2020

In patients with rare forms of epilepsy, artisanal CBD increased seizures while pharmaceutical CBD caused seizure reduction. Continue reading You Should Reconsider Using Store-Bought CBD To Treat Seizures at The Fresh Toast.

CBD 52

CBD Epilepsy Pharmaceutical Patients 52

Canna Care Docs

SEPTEMBER 18, 2020

You must be a legal resident of Virginia who is able to prove residency in order to apply for a Virginia medical cannabis card. Patients under the age of 18 must also have a parent or guardian registered as a caregiver on their behalf. Patients may purchase a 90 day supply of their medication.

Pharmaceutical 98

Pharmaceutical Conditions Patients Oil 98

Cannabis Law Report

JANUARY 5, 2022

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by delaying aging, announced that the U.S. About MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Clinical Trials Therapy Treatment 52

Veriheal

AUGUST 2, 2023

That’s right; cannabis could be very beneficial in your mission to remain mindful while parenting. Let’s explore five reasons why many parents are choosing to utilize cannabis as a tool in their parenting repository. Cannabis can be a helpful tool for mindful parenting when you want to let loose a little.

Microdosing 94

Microdosing Consumption Pharmaceutical Cannabis 94

Cannabis Law Report

DECEMBER 18, 2019

…MGC Pharmaceuticals has achieved yet another significant milestone with the bio-pharma company this week surpassing more than 1,800 prescribed products of its medicinal cannabis-based pharmaceutical products in Australia, UK, Brazil and Ireland. The West Australian reports. Source: [link].

Research and Development 59

Research and Development Clinical Trials Seed-To-Sale Pharmaceutical 59